{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:03:39Z","timestamp":1779185019582,"version":"3.51.4"},"reference-count":222,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":10168,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1985,5,6]]},"abstract":"<jats:p>The authors review four \u201csecond generation\u201d antidepressants (maprotiline, amoxapine, trazodone, and nomifensine) in terms of action on biogenic amines and receptors, antidepressive efficacy, and adverse effects. Doxepin is used as a comparative agent and is similar to the prototypical tricyclic agents in all the above categories. Maprotiline is a selective noradrenergic agent, but shares a similar adverse effect profile with doxepin and may be associated with a high frequency of seizures in overdose. Amoxapine is a mixed action antidepressant with significant neuroleptic activity in vivo. Its adverse effect profile is highlighted by symptoms related to its neuroleptic activity, and seizures and acute renal failure in overdose. Trazodone is a selective serotonergic agent with low anticholinergic activity, and minimal morbidity\/mortality in overdose. Reports of priapism, leading to impotence in some men, however, is of concern. Nomifensine is a potent noradrenergic and dopaminergic agent with low anticholinergic activity, and minimum cardiotoxicity and low morbidity\/mortality in overdose. Its most important adverse effects include overstimulation and infrequent, usually reversible, immunologic hypersensitivity reactions. Trazodone and nomifensine have favorable profiles for use in the elderly. Trazodone may be more favorable in the anxious\/agitated patient due to its sedative effects, whereas nomifensine may be more beneficial in the retarded, apathetic patient.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1985.tb02835.x","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:37:44Z","timestamp":1362789464000},"page":"241-260","source":"Crossref","is-referenced-by-count":64,"title":["Second Generation Antidepressants: A Comparative Review"],"prefix":"10.1002","volume":"25","author":[{"given":"Emil F.","family":"Coccaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J.","family":"Siever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.122.5.509"},{"key":"e_1_2_1_3_2","volume-title":"The Biology of the Major Psychoses.","author":"Goodwin FK","year":"1975"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0364-7722(78)90019-X"},{"key":"e_1_2_1_5_2","first-page":"131","article-title":"New studies and perspectives on the noradrenergic receptor system in depression: Effects of the alpha\u20102\u2010adrenergic agonist clonidine","volume":"19","author":"Siever LJ","year":"1984","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780350094011"},{"key":"e_1_2_1_7_2","first-page":"219","article-title":"The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction","volume":"3","author":"Vohra J","year":"1975","journal-title":"Eur J Cardiol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.49"},{"key":"e_1_2_1_9_2","first-page":"17","article-title":"Central action of 11\u2010(3\u2010dimethyl\u2010ammopropylidene)\u20106,11\u2010dihydro\u2010dibenzo[b,e] oxepin hydrochloride (doxepin)","volume":"25","author":"Zielinski M","year":"1973","journal-title":"Pol J Pharmacol Pharm"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00403619"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1974.tb09231.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429685"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978235573"},{"key":"e_1_2_1_14_2","first-page":"213","article-title":"The newer antidepressants: Structures, pharmacokinetics and proposed mechanisms of action","volume":"20","author":"Richelson E","year":"1984","journal-title":"Psychopharm Bull"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(71)90216-4"},{"key":"e_1_2_1_16_2","first-page":"113","volume-title":"Depressive Illness","author":"Delini\u2010Stula A","year":"1972"},{"key":"e_1_2_1_17_2","first-page":"3","article-title":"Depression and antidepressants\u2014new aspects and hypotheses","volume":"7","author":"Delini\u2010Stula A","year":"1980","journal-title":"Br J Clin Pract"},{"key":"e_1_2_1_18_2","first-page":"297","article-title":"Effect of maprotaline, a new antidepressant drug, on serotonin uptake","volume":"10","author":"Maitre L","year":"1974","journal-title":"Adv Biochem Psychopharmacol"},{"issue":"2","key":"e_1_2_1_19_2","first-page":"2","article-title":"Maprotiline, its position as an antidepressant in light of recent neuropharmacologic and neurobiochemical findings","volume":"3","author":"Maitre L","year":"1975","journal-title":"J Int Med Res"},{"issue":"3","key":"e_1_2_1_20_2","first-page":"33","article-title":"Effects of chloripramine and other tricyclic antidepressants on biogenic amine uptake and turnover","volume":"52","author":"Waldmeier PC","year":"1976","journal-title":"Post Grad Med J"},{"key":"e_1_2_1_21_2","volume-title":"Depressive Illness","author":"Reiss W","year":"1972"},{"issue":"2","key":"e_1_2_1_22_2","first-page":"16","article-title":"The pharmacokinetic properties of maprotiline in man","volume":"3","author":"Reiss W","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1981.tb02538.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600680224"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(76)90261-4"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/0006-2952(79)90017-0","article-title":"Amoxapine, an antidepressant with antipsychotic properties\u2014a possible role for 7\u2010hydroxyamoxpaine","volume":"28","author":"Coupet J","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/ajp.139.9.1165","article-title":"Amoxapine: Neuroleptic as well as antidepressant?","volume":"139","author":"Cohen BM","year":"1982","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_28_2","first-page":"1","article-title":"Amoxapine","volume":"2","author":"Greenblatt EN","year":"1979","journal-title":"Pharmacol Biochem Prop Drug Subst"},{"key":"e_1_2_1_29_2","first-page":"107","article-title":"The neuropharmacological actions of amoxapine","volume":"233","author":"Greenblatt EN","year":"1978","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808201600302"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197910000-00009"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198111001-00004"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(76)90364-7"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90165-9"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90197-5"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(68)90069-5"},{"key":"e_1_2_1_37_2","first-page":"18","article-title":"Pharmacological and biochemical features of trazodone","volume":"9","author":"Boissier JR","year":"1974","journal-title":"Med Prob Pharmacopsychiat"},{"key":"e_1_2_1_38_2","first-page":"410","article-title":"Experimental and clinical data indicating a potential use for trazodone in acute stroke","volume":"18","author":"Allori L","year":"1975","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_39_2","first-page":"25","article-title":"On the central antiserotonin action of trazodone","volume":"33","author":"Baran L","year":"1979","journal-title":"Pol J Pharmacol Pharm"},{"key":"e_1_2_1_40_2","first-page":"299","article-title":"Effect of Trazodone on the firing rate of central monoaminergic neurons. Comparison with various antidepressants","volume":"260","author":"Scuvee\u2010Moreau JS","year":"1982","journal-title":"Arch Int Pharmacodyn"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(81)90198-2"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000136707"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(79)90164-3"},{"key":"e_1_2_1_44_2","first-page":"70","volume-title":"Antidepressants: Neurochemical Behavioral and Clinical Perspectives.","author":"Peroutka SJ","year":"1981"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198121060-00001"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)97841-5"},{"key":"e_1_2_1_47_2","first-page":"2084","article-title":"Pharmacokinetik und stoffwechsel von trazodone beim menschen","volume":"26","author":"Jauch VR","year":"1976","journal-title":"Arzneimittel-Forschung"},{"issue":"1","key":"e_1_2_1_48_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000468598","article-title":"Pharmacology of nomifensine","volume":"17","author":"Hoffman I","year":"1982","journal-title":"Int Pharmacopsychiatry"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00492370"},{"key":"e_1_2_1_50_2","first-page":"649","article-title":"Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synapto\u2010somal preparations of rat brain","volume":"199","author":"Koe BK","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7197394"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90411-1"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(79)90217-X"},{"key":"e_1_2_1_54_2","volume-title":"Advances in Pharmacology and Therapeutics","author":"Woodruff GN","year":"1979"},{"key":"e_1_2_1_55_2","first-page":"675","article-title":"Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d\u2010amphetamine, methylphenidate and nomifensine","volume":"12","author":"Algeri S","year":"1980","journal-title":"Pharmacol Res Commun"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00499215"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/268455a0"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1977.tb05749.x"},{"key":"e_1_2_1_59_2","volume-title":"Nomifensine","author":"Leonard BE","year":"1980"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(82)90059-2"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00569405"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb14570.x"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431726"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1981.tb13912.x"},{"issue":"1","key":"e_1_2_1_65_2","first-page":"35","article-title":"Hyposalivation after single doses of antidepressants","volume":"18","author":"Mikkelson PL","year":"1982","journal-title":"Int Pharmacopsychiatry"},{"key":"e_1_2_1_66_2","first-page":"21","article-title":"Kinetics and metabolism of nomifensine","volume":"45","author":"Heptner W","year":"1984","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"e_1_2_1_67_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000468601","article-title":"The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco\u2010EEG","volume":"17","author":"Saletu B","year":"1982","journal-title":"Int Pharmacopsychiatry"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197713030-00001"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197713050-00001"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197918010-00001"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198224010-00001"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1978.tb06885.x"},{"key":"e_1_2_1_73_2","first-page":"449","article-title":"Therapeutic superiority of maprotiline versus doxepine in geriatric depression","volume":"44","author":"Gwirtsman HE","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_74_2","first-page":"248","article-title":"Onset of action of amoxapine and doxepine in outpatients with \u201cMixed Anxiety\/Depression.\u201d","volume":"44","author":"Hekimian LJ","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1159\/000284090"},{"key":"e_1_2_1_76_2","volume-title":"Typical and Atypical Antidepressants: Clinical Practice","author":"Scardigli G","year":"1982"},{"issue":"1","key":"e_1_2_1_77_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000468603","article-title":"Nomifensine and maprotaline in endogenous depression: Comparative efficacy and side effects","volume":"17","author":"Levin A","year":"1982","journal-title":"Int Pharmacopsychiatry"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1159\/000284097"},{"key":"e_1_2_1_79_2","first-page":"96","article-title":"An overview of side effects and long\u2010term experience with nomifensine from United States Clinical Trials","volume":"45","author":"Yakabow AL","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.163.3874.1467"},{"key":"e_1_2_1_81_2","first-page":"66","article-title":"Psychomotor skills during acute and two\u2010week treatment with mianserin (Org GB 94) and amitriptyline and their combined effects with alcohol","volume":"9","author":"Seppala T","year":"1977","journal-title":"Ann Clin Res"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057800600602"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00988.x"},{"key":"e_1_2_1_84_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1981.tb00732.x"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb11115.x"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426327"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1977.tb05747.x"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb00841.x"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975175515"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426774"},{"key":"e_1_2_1_91_2","first-page":"337","article-title":"Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects","volume":"20","author":"Karniol IG","year":"1976","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_92_2","first-page":"47","article-title":"The effects of nomifensine and HOE 8476 on car driving and related psychomotor performance","volume":"25","author":"Hindmarch I","year":"1980","journal-title":"Roy Soc Med Int Cong Symp Series"},{"key":"e_1_2_1_93_2","volume-title":"Relevance of screening tests in human psychopharmacology: The psychological point of view (Human screening tests for the clinical investigation of nomifensine)","author":"Taeuber K","year":"1974"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780320095011"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1975.03240250034022"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.8.1006"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(69)71749-2"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.129.4.335"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/0364-7722(77)90058-3"},{"key":"e_1_2_1_100_2","first-page":"39","article-title":"Doxepin and imipramine in the treatment of depression: A double\u2010blind crossover clinical study with EKG recordings","volume":"14","author":"Amin MM","year":"1978","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198204223061603"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198212000-00034"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00500343"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563657908992441"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(74)90130-7"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1980.tb01557.x"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00570267"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(80)90509-3"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1982.tb06570.x"},{"key":"e_1_2_1_110_2","first-page":"423","article-title":"Ventricular arrhythmias induced by doxepin and amitryptiline: Case report","volume":"44","author":"Todd RD","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01990085"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb07734.x"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb04570.x"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563658308990069"},{"key":"e_1_2_1_115_2","volume-title":"Depressive Illness","author":"Reale A","year":"1972"},{"key":"e_1_2_1_116_2","volume-title":"Depressive Illness","author":"Imhof P","year":"1972"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1974.tb00219.x"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198207000-00002"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb05872.x"},{"key":"e_1_2_1_120_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/030006057600400106","article-title":"Antidepressant treatment with maprotiline in the management emotional disturbances in patients with acute myocardial infarction: A controlled study","volume":"4","author":"Selvini A","year":"1976","journal-title":"J Int Med Res"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6182.102"},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1978.tb14901.x"},{"key":"e_1_2_1_123_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03280300045019"},{"key":"e_1_2_1_124_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808401800908"},{"key":"e_1_2_1_125_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03330090062031"},{"key":"e_1_2_1_126_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-4-463"},{"key":"e_1_2_1_127_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563658308990055"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.11.1503"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198308000-00010"},{"key":"e_1_2_1_130_2","first-page":"59","article-title":"Amoxapine and heart disease","volume":"4","author":"Hertzman M","year":"1984","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(78)90065-3"},{"key":"e_1_2_1_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90496-5"},{"key":"e_1_2_1_133_2","first-page":"259","article-title":"Differential effects of trazodone and imipramine on intracardiac conduction in the anesthetized dog","volume":"259","author":"Byrne JE","year":"1982","journal-title":"Arch Int Pharmacodyn"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00605991"},{"issue":"2","key":"e_1_2_1_135_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000284094","article-title":"A double\u2010blind non\u2010crossover placebo\u2010controlled study between group comparison of trazodone and amitriptyline on cardiovascular function in major depressive disorder","volume":"17","author":"Merew TJ","year":"1984","journal-title":"Psychophathology"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.194"},{"key":"e_1_2_1_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90717-2"},{"key":"e_1_2_1_138_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.6.796"},{"key":"e_1_2_1_139_2","first-page":"119","article-title":"Trazodone and cardiovascular side effects","volume":"4","author":"Pellettier JR","year":"1984","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_140_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.11.1472"},{"key":"e_1_2_1_141_2","doi-asserted-by":"publisher","DOI":"10.1159\/000284093"},{"key":"e_1_2_1_142_2","doi-asserted-by":"publisher","DOI":"10.1159\/000284095"},{"key":"e_1_2_1_143_2","first-page":"10","article-title":"Trazodone overdose","volume":"139","author":"Lippman S","year":"1982","journal-title":"Am J Psychiatry;"},{"key":"e_1_2_1_144_2","doi-asserted-by":"crossref","unstructured":"DumovicP BurrowsGD VohraJet al:Cardiological studies with nomifensine. Abstract No. 115 in ASCEP Proceedings Sydney November 1977.","DOI":"10.1016\/B978-0-08-023768-8.52180-0"},{"key":"e_1_2_1_145_2","volume-title":"Symposium uber Ergebnisse der experimentellen und klinischen Prufung","author":"Biamino G","year":"1977"},{"key":"e_1_2_1_146_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1978.tb107898.x"},{"key":"e_1_2_1_147_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198201000-00023"},{"key":"e_1_2_1_148_2","volume-title":"Relevance of screening tests in human psychopharmacology: The psychological point of view (human screening tests for the clinical investigation of nomifensine)","author":"Taeuber K","year":"1974"},{"key":"e_1_2_1_149_2","volume-title":"Symposium uber Ergenisse der experimentellen und klinischen Prufung","author":"Fleckenstein G","year":"1977"},{"key":"e_1_2_1_150_2","first-page":"141","article-title":"Acute poisoning by nomifensine","volume":"2","author":"Garnier R","year":"1982","journal-title":"J Toxicol Med"},{"key":"e_1_2_1_151_2","first-page":"89","article-title":"A review of the clinical safety and tolerability of nomifensine","volume":"45","author":"Stonier PD","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_152_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6417.601"},{"key":"e_1_2_1_153_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1983.tb03733.x"},{"key":"e_1_2_1_154_2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jama.1983.03340080047027","article-title":"Amoxapine overdose","volume":"250","author":"Litovitz TL","year":"1983","journal-title":"JAMA"},{"key":"e_1_2_1_155_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6126.1523"},{"key":"e_1_2_1_156_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6142.961-c"},{"key":"e_1_2_1_157_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.55.648.742"},{"key":"e_1_2_1_158_2","first-page":"434","article-title":"Seizures and maprotiline","volume":"43","author":"Bick P","year":"1982","journal-title":"J Clin Psych"},{"key":"e_1_2_1_159_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.2.244"},{"key":"e_1_2_1_160_2","first-page":"845","article-title":"Seizures associated with maprotiline","volume":"139","author":"Kim WY","year":"1982","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_161_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.5.673"},{"key":"e_1_2_1_162_2","first-page":"117","article-title":"Maprotiline and seizures","volume":"43","author":"Hoffman BF","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_163_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.8.1080-b"},{"key":"e_1_2_1_164_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.4.509b"},{"key":"e_1_2_1_165_2","doi-asserted-by":"publisher","DOI":"10.1159\/000406235"},{"key":"e_1_2_1_166_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057700500107"},{"key":"e_1_2_1_167_2","first-page":"39","article-title":"Epilepsy, antidepressants, and the role of nomifensine","author":"Trimble MR","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_168_2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archinte.1981.00340080063015","article-title":"The effect amoxapine and imipramine on serum prolactin levels","volume":"141","author":"Cooper DS","year":"1981","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_169_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428168"},{"key":"e_1_2_1_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(83)90020-4"},{"key":"e_1_2_1_171_2","first-page":"821","article-title":"Galactorrhea in a patient treated with amoxapine","volume":"39","author":"Jaffe K","year":"1978","journal-title":"J Clin Psych"},{"key":"e_1_2_1_172_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03300170046029"},{"key":"e_1_2_1_173_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.11.1500"},{"key":"e_1_2_1_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(84)73098-2"},{"key":"e_1_2_1_175_2","first-page":"381","article-title":"Clinical trial of amoxapine (CL67,772) with depressed patients","volume":"14","author":"Ota KY","year":"1972","journal-title":"Clin Ther Res"},{"key":"e_1_2_1_176_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.1.115"},{"key":"e_1_2_1_177_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.8.1102-b"},{"key":"e_1_2_1_178_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.2.283"},{"key":"e_1_2_1_179_2","first-page":"657","article-title":"Amoxapine: A clinical evaluation in depressive syndromes","volume":"14","author":"Charalampous KD","year":"1972","journal-title":"Clin Ther Res"},{"key":"e_1_2_1_180_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.9.1233"},{"key":"e_1_2_1_181_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.5.704"},{"key":"e_1_2_1_182_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198308000-00049"},{"key":"e_1_2_1_183_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.10.1358"},{"key":"e_1_2_1_184_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.11.1515"},{"key":"e_1_2_1_185_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.4.493"},{"key":"e_1_2_1_186_2","first-page":"125","article-title":"Tardive dyskinesia and depressive illness","volume":"2","author":"Davis KL","year":"1976","journal-title":"Psychopharmacol Comm"},{"key":"e_1_2_1_187_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.2.233"},{"key":"e_1_2_1_188_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.2.234"},{"key":"e_1_2_1_189_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.9.1220-b"},{"key":"e_1_2_1_190_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.6.750"},{"key":"e_1_2_1_191_2","first-page":"787","article-title":"Effect of antidepressant on genito\u2010urinary function","volume":"26","author":"Simpson GM","year":"1965","journal-title":"Dis Nerv Syst"},{"key":"e_1_2_1_192_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.1.82"},{"key":"e_1_2_1_193_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1980.00040020975020"},{"key":"e_1_2_1_194_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1983.00350080031008"},{"key":"e_1_2_1_195_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.10.1362"},{"key":"e_1_2_1_196_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92307-9"},{"key":"e_1_2_1_197_2","first-page":"35","volume":"26","author":"Priapism with Trazodone.","year":"1984","journal-title":"The Medical Letter"},{"issue":"1","key":"e_1_2_1_198_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000468604","article-title":"A double\u2010blind clinical comparison between nomifensine and maitriptyline in the treatment of endogenous depressions","volume":"17","author":"Alino Lopez\u2010Ibor JJ","year":"1982","journal-title":"Int Pharmacopsychiat"},{"key":"e_1_2_1_199_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.138.5.439a"},{"key":"e_1_2_1_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90144-2"},{"key":"e_1_2_1_201_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01716458"},{"key":"e_1_2_1_202_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91171-0"},{"key":"e_1_2_1_203_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.281.6252.1392-a"},{"key":"e_1_2_1_204_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780260728"},{"key":"e_1_2_1_205_2","first-page":"258","article-title":"Side effects of Merital\u00ae (nomifensine)","volume":"3","author":"Ames D","year":"1983","journal-title":"Med J Aust"},{"key":"e_1_2_1_206_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198223060-00002"},{"key":"e_1_2_1_207_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.55.646.528"},{"key":"e_1_2_1_208_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03330090062031"},{"key":"e_1_2_1_209_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-4-463"},{"key":"e_1_2_1_210_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1984.03340290021006"},{"key":"e_1_2_1_211_2","first-page":"426","article-title":"Amoxapine\u2010associated rhabdomyolysis and acute renal failure: Case report","volume":"43","author":"Abreo K","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_212_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03330230053033"},{"key":"e_1_2_1_213_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770350030002"},{"key":"e_1_2_1_214_2","volume-title":"Studies in Geriatric Psychiatry","author":"Gianturco DP","year":"1978"},{"key":"e_1_2_1_215_2","first-page":"1530","article-title":"Clinical evaluation of the antidepressants maprotiline and amitriptyline. A double\u2010blind controlled trial","volume":"48","author":"Marais GFT","year":"1974","journal-title":"South Afr Med J"},{"issue":"2","key":"e_1_2_1_216_2","first-page":"75","article-title":"A controlled comparison of maprotiline (Ludiomil\u00ae) with imipramine avoiding observer bias","volume":"3","author":"Levine S","year":"1975","journal-title":"J Int Med Res"},{"key":"e_1_2_1_217_2","first-page":"216","article-title":"Treatment of geriatric depression with trazodone, imipramine, and placebo: A double\u2010blind study","volume":"46","author":"Gerner R","year":"1980","journal-title":"J Clin Psychiat"},{"key":"e_1_2_1_218_2","first-page":"73","article-title":"A double\u2010blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients","volume":"45","author":"Merideth CH","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_219_2","first-page":"68","article-title":"A two\u2010center double\u2010blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients","volume":"45","author":"Cohn JB","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_220_2","first-page":"287","article-title":"Nomifensine in the treatment of depressed geriatric patients","volume":"43","author":"Goldstein SE","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_221_2","first-page":"33","article-title":"Pharmacodynamics of nomifensine: A review of studies in healthy subjects","volume":"45","author":"Siegfried K","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_222_2","first-page":"63","article-title":"Nomifensine in geriatric inpatients: A placebo\u2010controlled study","volume":"45","author":"Jansen W","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_223_2","doi-asserted-by":"publisher","DOI":"10.1177\/096032718400300207"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1985.tb02835.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1985.tb02835.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:38:47Z","timestamp":1697891927000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1985.tb02835.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,5,6]]},"references-count":222,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985,5,6]]}},"alternative-id":["10.1002\/j.1552-4604.1985.tb02835.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1985.tb02835.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,5,6]]}}}